Biotech China 2014

Cancer Biology: Duke University

Total Score People Score Events Score
114 91 52
Date Event Presentation Speakers
January 30, 2014 Genitourinary Cancers Symposium Welcome and General Session 1: Integration of New Androgen Therapy in Locally Advanced Treatment Andrew J Armstrong
April 6, 2013 AACR Annual Meetings The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Jeremy N. Rich
September 13, 2012 International Society of Gastrointestinal Oncology Session 4 | Hot Topics in Gastrointestinal Oncology Christopher Willett
Case Presentations/Panel Discussion | Case 1: Rectal Cancer with Resectable Liver Metastases Brian G. Czito
August 21, 2011 The TGF-β Superfamily: Signaling in Development and Disease TGF-β, microRNAs and tumor metastasis Xiao-Fan Wang
Session 3 | TGF-ß and Cancer Xiao-Fan Wang
May 18, 2011 SBI 10th Postgraduate Course Updates in Imaging | Nuclear Medicine in Breast Imaging Jay A. Baker
May 2, 2011 LIPID MAPS Annual Meeting 2011: Lipidomics Impact on Cell Biology, Cancer, and Metabolic Diseases Metabolic profiling for understanding of obesity and diabetes mechanisms Christopher B. Newgard
Diversity and function of enzymes that dephosphorylate phosphatidylglycerolphosphate Christian Raetz
April 29, 2011 Duke Debates: Controversies in the Management of Patients With Hematologic Malignancies SESSION 2 | Welcome and Introductions Patrick Buckley
Simultaneous Session 2 | Practical Hematopathology | Cells, Chromosomes, and Molecules in AML—Providing Insights Into Classification, Diagnosis, and Prognosis Patrick Buckley
Session 1 | Management of Diabetes in the Oncology Patient Angela Johns
SESSION 2 | Recurrent Molecular Mutations in Acute Myeloid Leukemia Michael B. Datto
SESSION 2 | Determining Immunophenotype in Acute Myeloid Leukemia | At Diagnosis and Beyond Anand Shreeram Lagoo
SESSION 2 | Current Classification of Acute Myeloid Leukemia | Implications of Dysplastic Changes and Cytogenetic and Molecular Abnormalities Patrick Buckley
Debate | Therapy for secondary leukemia in the “robust” elderly patient Arati Rao
Personalizing Health Care Through Genomic Profiling Sandeep S. Dave
Debate | Induction therapy for patients with acute lymphoblastic leukemia should contain asparaginase. Mitchell Horwitz
Debate | Options for chronic myeloid leukemia induction therapy | the choice for a new generation? Joseph Moore
Welcome and Presession Survey Joseph Moore
Leukemia Session Joseph Moore
New Options in Hodgkin Lymphoma Anne W. Beaven
The Future of Chronic Lymphocytic Leukemia Therapy Mark C. Lanasa
Debate | Bendamustine | rituximab is the standard of care for induction therapy of follicular lymphoma. Anne W. Beaven
Welcome and Presession Survey Anne W. Beaven
Lymphoma Session Anne W. Beaven
March 3, 2011 Stem Cells, Development, and Cancer Title to be announced Brigid Hogan
February 27, 2011 Signal Transduction within the Nucleus Gordon Research Conference Partitioning the mRNA transcriptome: Bimodal regulation of mRNA localization to the endoplasmic reticulum Chris Nicchitta
Nuclear Inositide and Lipid Signaling John York
December 8, 2010 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium Drug Development – Targeting HER2 Beyond Trastuzumab Neil L Spector
The Upside of Irrationality Dan Ariely
November 7, 2010 Ninth Annual International Conference on Frontiers in Cancer Prevention Research Molecular approaches to early detection of pancreatic cancer Caroline Hollingsworth
October 27, 2010 Colorectal Cancer: Biology to Therapy Efficacy and toxicity of VEGF inhibitors: Predictive markers and biological insights Herbert Hurwitz
October 20, 2010 6th Annual Meeting of the Oligonucleotide Therapeutics Society Combinatorial mRNA Control Jack Keene
Session XI: Aptamers Bruce A. Sullenger
Using Nucleic Acid Binding Polymers to Control Aptamers and Inflammation Bruce A. Sullenger
September 30, 2010 Third AACR Conference on The Science of Cancer Health Disparities Disparities in screening and primary treatment for prostate cancer Stephen J. Freedland
American College of Surgeons Oncology Group and cancer health disparities in clinical trials David M. Ota
September 30, 2010 Third AACR Conference on the Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved Disparities in screening and primary treatment for prostate cancer Stephen J. Freedland
American College of Surgeons Oncology Group and cancer health disparities in clinical trials David M. Ota
September 3, 2010 Fourth Asian Pacific Conference: Perspectives in Lung Cancer The art of radical surgery David Harpole
Metagene or magic gene David Harpole
July 11, 2010 Translational Cancer Medicine 2010 (USA) Utilization of genomic signatures to guide therapeutic decisions Joseph R. Nevins
July 7, 2010 WIN Symposium in personalized cancer medicine Rationale genomic approaches to dissect lung cancer biology: a clue for clinical application. ANIL POTTI
July 4, 2010 The Multiple Tiers of Gene Regulation in Cancer Opening Session and AICR Colin Thomson Memorial Lecture Joseph R. Nevins
June 1, 2010 Emerging Themes in Infection Biology Viruses, microRNAs and RNA interference Bryan Cullen
May 4, 2010 Biomarker World Congress 2010 Evolutionary Genetics of Alzheimer’s Disease Allen D. Roses
May 3, 2010 LIPID MAPS Annual Meeting 2010: Lipidomics Impact on Cell Biology, Atherosclerosis and Inflammatory Disease Elucidation of prenol lipid pathways by combining genetics and mass spectrometry Christian Raetz
April 9, 2010 Duke Debates: Controversies in the Management of Patients With Hematologic Malignancies The Biologic Significance of Clonal T-Cells | Session 2 Michael B. Datto
CD30-Positive and Other Cutaneous T-Cell Proliferations | Session 2 Patrick Buckley
General Principles in Treating T-Cell Lymphomas | Session 2 Anne W. Beaven
Classification of T-Cell Lymphomas | Session 2 Anand Shreeram Lagoo
Welcome, Introductions and Presession Survey | Session 2 Patrick Buckley
Simultaneous Session 2 Practical Hematopathology: T-Cell Lymphomas Patrick Buckley
Palliative and End-of-Life Care Gwynn D. Long
Pharmacy Session Tippu Khan
Transplantation Therese Hennig
Treatment Options Patricia H. Davis
Pathophysiology and Diagnosis Mark C. Lanasa
Welcome and Presession Survey Joseph Moore
Leukemia Session Joseph Moore
Interesting Cases and Postsession Survey | Session 2 Anne W. Beaven, Patrick Buckley, Anand Shreeram Lagoo
Case-Based Presentation Myeloproliferative Neoplasms: What Are We All JAKed Up About? Murat O. Arcasoy
Debate Allogeneic Transplantation Is Standard for All Patients Aged < 55 Years With AML in First Remission Who Do Not Have Good-Risk Cytogenetics Nelson J. Chao, Jon Gockerman
The Future of Personalized Therapy: The Application of Genomics and MicroRNA in Guiding Therapy Sandeep S. Dave
Debate Patients With Philadelphia Chromosome–Positive ALL: Transplant Now or Later? Gwynn D. Long
Debate Transplantation vs. Novel, Less Lethal Approaches to MDS Carlos de Castro, Mitchell Horwitz
Bone Marrow Transplantation Workshop Nelson J. Chao
Debate The Best Therapy for Elderly Patients With AML: 7+3 Is Good Enough for Me! Joseph Moore, Arati Rao
Use of New Stem Cell Mobilization Agents for Patients and Healthy Donors Mitchell Horwitz
Recent Advances in Posttransplantation Immune Modulation Following Nonablative Allogeneic Transplantation David Rizzieri
Recent Advances in Cord Blood Transplantation Nelson J. Chao
Debate Fludarabine-Based Regimens Are the Preferred First-line Approach to Patients With CLL David Rizzieri, Mark C. Lanasa
Debate Induction Therapy in Preparation for Transplantation: Immunomodulator or Proteasome Inhibitor? Cristina Gasparetto
How I Treat High-Risk DLBCL Anne W. Beaven
Keynote Address New Therapies for PNH Wendell F. Rosse
Welcome and Presession Survey David Rizzieri
Lymphoma Session Anne W. Beaven
November 19, 2009 Stem Cells 2009 Mechanisms of cardiac regeneration in zebrafish Ken Poss
September 24, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual clinical biomarkers Using Proteomics and Established Patient Cohorts to Address Relevant Clinical Biomarker Needs: The MURDOCK Study J. Will Thompson
September 21, 2009 Next-Generation Sequencing Data Analysis So My Genome Costs Less Than My Bike: What’s the Big Deal? Robert Cook-Deegan
September 21, 2009 Third Annual Exploring Next Generation Sequencing So My Genome Costs Less Than My Bike: What’s the Big Deal? Robert Cook-Deegan
June 9, 2009 Genomic Sample Prep Translating Small Genetic Contributions into Large Effects Using Phylogenetic Analyses Allen Roses
June 9, 2009 Third Annual Cardiotoxicity and Drug Safety Critical Path Meets Cardiac Safety: A Novel, Collaborative Paradigm for Cardiac Safety Evaluation Mitchell W. Krucoff
June 8, 2009 The Business of Genomics Translating Small Genetic Contributions into Large Effects Using Phylogenetic Analyses Allen Roses
February 7, 2009 Translation of the Cancer Genome SESSION 7: TRANSLATIONAL MEDICINE Joseph R. Nevins
December 7, 2008 AMERICAN SOCIETY FOR MATRIX BIOLOGY 2008 Meeting Location Matters: Matrix Regulation of Lung Inflammation and Remodeling Paul W. Noble
Concurrent N: Factors affecting splicing of scleroderma-associated LH2 mRNA Seth Puneet,
November 4, 2008 The Chemotherapy Foundation Symposium XXVI OR Chemotherapy Foundation Symposium, Innovative Cancer Therapy for Tomorrow UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION Vinod K. Prasad
AN UPDATE OF ESAs IN ONCOLOGY Jeffrey Crawford
TRANSPLANT-RELATED INFECTIONS: THE CHALLENGE CONTINUES Angela Johns
September 5, 2008 44th ASCO Annual Meeting General Session III: Radiation: Basics and Beyond Lawrence B Marks
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Faculty H Kim Lyerly, Neil Spector, Raj K. Puri
Introduction H Kim Lyerly
Panel Discussion: Obstacles to Development--Ten Barriers to Proving Agents are Effective and Safe Kim H Lyerly
Proof of Concept to the Clinical Investigator: What are Meaningful Endpoints in Early Stage Development Neil Spector
Panel Discussion Neil Spector
Cancer Vaccines and Immunotherapy H Kim Lyerly, Raj K. Puri
May 30, 2008 44th ASCO Annual Meeting Program Committee Christopher Willett
Program Committee Daniel George, W Robert Lee
May 30, 2008 ASCO Annual'08 Meeting cancer prevention/epidemiology-- Cohort Identification for Cancer Prevention and Early Detection: Risk in the Balance Michael J. Kelley
geriatric oncology-- Internal Medicine for the Oncologist Harvey Jay Cohen
health services research-- Cancer and Thrombosis I: The Risk of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
health services research-- Cancer and Thrombosis II: The Prevention of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
health services research-- Cancer and Thrombosis III: The Role of Anticoagulation in the Treatment of Patients with Cancer Gary H. Lyman
patient and survivor care-- Cancer and Thrombosis I: The Risk of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
patient and survivor care-- Cancer and Thrombosis II: The Prevention of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
patient and survivor care-- Cancer and Thrombosis III: The Role of Anticoagulation in the Treatment of Patients with Cancer Gary H. Lyman
tumor biology-- Cohort Identification for Cancer Prevention and Early Detection: Risk in the Balance Michael J. Kelley
March 25, 2008 Molecular Diagnostics Prospective Medicine: The Next Health Care Transformation Ralph Snyderman
An Integrated Genomic Approach for Treatment of Patients with Advanced Ovarian Cancer Holly K Dressman
March 25, 2008 Clinical Trials Asia Trials and Tribulations of Conducting Clinical Studies in India: Vasantha P Rao
March 25, 2008 CANCER MOLECULAR MARKERS An Integrated Genomic Approach for the Treatment of Patients with Advanced Stage Ovarian Cancer Holly K Dressman
March 9, 2008 DNA DAMAGE, MUTATION & CANCER DNA-lesion-recognition Complexes Lorena S Beese
February 10, 2008 GRC - Prolactin & Growth Hormone Family Metabolic actions of PRL and GH Michael Freemark
December 1, 2007 47TH American Socieity of Cell Biology Translocation of Mammalian Lipid Droplets into the Chlamydia trachomatis Parasitopherous Vacuole. Raphael H Valdivia
Neuronal Cell Biology Michael D Ehlers
Positioning Endocytic Zones and AMPA Receptor Cycling in Dendritic Spines. Michael D Ehlers, J Lu, T D Helton, T A. Blanpied, T M Newpher
Structural Integrity of the Mature Neuromuscular Junction Requires an Ankyrin-B-dependent Localization of β- G. Ayalon, V Bennett, J. Q. Davis
Chromatin Architecture and Remodeling Laura Rusche
Building Silent Chromatin: Dynamics of SIR Spreading in Yeast. Laura Rusche, P Lynch
The Role of Cell Traction Force in Fibronectin Fibrillogenesis. Harold P Erickson
Stem Cells, Small RNAs, and Self-Renewal. S Grivna
November 15, 2007 2007 Fourth International Conference Keynote #1 Overview of CAM Science Ralph Snyderman
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 11: Anti-Infectious Drug Discovery & Development (II) (09:00-12:20) Li Huang
Session 11: Small Molecules with Novel Mechanisms of Action and Potent Anti-HIV-1 Activity Against Multiple Genetic Subtypes of HIV-1 (10:40-11:00) Li Huang
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Plenary Session 4: New Trials and Genomic-based Design Stephen L GEORGE, Joseph R. Nevins
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) NUCLEAR HORMONE RECEPTORS (14:10-18:50) Julie M. Hall
NUCLEAR HORMONE RECEPTORS: Pro-Inflammatory Actions of Thiazolidinediones (TZDs) in Macrophages: Mechanism and Implications for Human Health (15:15-15:45) Julie M. Hall
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Eight Annual Metabolic Biomarkers: METABOLIC BIOMARKER DISCOVERY (08:30-11:00) Rima Kaddurah-Daouk Kaddurah-Daouk
Eight Annual Metabolic Biomarkers; METABOLIC BIOMARKER DISCOVERY: METABOLIC BIOMARKER DISCOVERY: Metabolomics for Mapping Disease Signatures and Drug Response Phenotypes (08:35-09:05) Rima Kaddurah-Daouk Kaddurah-Daouk
August 11, 2007 Growth factor receptor tyrosine kinases in mitogenesis, morphogenesis Actin nucleation complexes and Abl tyrosine kinases in the regulation of morphogenesis and intercellular adhesion Ann M Pendergast
August 11, 2007 Lipid signaling Pathways in Cancer Synergy of DGKalpha and zeta in immune cell development, function and tolerance Xiao Ping Zhong
July 7, 2007 CHROMATIN AND TRANSCRIPTION An evolutionary relationship between heterochromatic and genespecific repression: the duplicated deacetylases Sir2p and Hst1p Laura Rusche
July 7, 2007 Protein Kinases and Protein Phosphorylation Regulation of intercellular adhesion by tyrosine kinases and actin nucleation machines Ann M Pendergast
Metabolic regulation of caspase-2 by calcium/calmodulindependent Sally A. Kornbluth
AKT phosphorylation of eNOS is required for tumor maintenance Christopher M. Counter
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.